M&A Deal Summary

Abbott Laboratories Acquires Visiogen

On October 20, 2010, Abbott Laboratories acquired medical products company Visiogen for 400M USD

Acquisition Highlights
  • This is Abbott Laboratories’ 10th transaction in the Medical Products sector.
  • This is Abbott Laboratories’ 16th largest (disclosed) transaction.
  • This is Abbott Laboratories’ 16th transaction in the United States.
  • This is Abbott Laboratories’ 8th transaction in California.

M&A Deal Summary
Date 2010-10-20
Target Visiogen
Sector Medical Products
Buyer(s) Abbott Laboratories
Deal Type Add-on Acquisition
Deal Value 400M USD

Target

Visiogen

Irvine, California, United States
website
Visiogen has developed an implantable device to improve vision impairment due to age-related presbyopia.

Search 192,611 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Abbott Laboratories

North Chicago, Illinois, United States

website

Category Company
Founded 1888
Sector Medical Products
Employees115,000
Revenue 43.7B USD (2022)
DESCRIPTION
Entrance to Abbott's corporate campus in Abbott Park, Illinois.
Entrance to Abbott's corporate campus in Abbott Park, Illinois.

Abbott Laboratories is a diversified, global provider of diagnostics, medical devices, nutrition and pharmaceuticals. Abbott Laboratories was incorporated in 1888 and is headquartered in North Chicago, Illinois.

DEAL STATS #
Overall 22 of 35
Sector (Medical Products) 10 of 20
Type (Add-on Acquisition) 22 of 35
State (California) 8 of 14
Country (United States) 16 of 27
Year (2010) 4 of 4
Size (of disclosed) 16 of 28
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-10-01 Abbott Laboratories S.A.

Madrid, Spain

Abbott Laboratories, S.A. (Spain) produces solid dose, sterile ointments, oral liquids, aerosols and topical products.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-01-07 AbbVie

North Chicago, Illinois, United States

AbbVie is a global, research-based biopharmaceutical company. AbbVie develops and markets advanced therapies that address complex and serious diseases. AbbVie's products are focused on treating conditions such as chronic autoimmune diseases, including rheumatoid arthritis, psoriasis, and Crohn's disease; low testosterone; HIV; endometriosis; thyroid disease; Parkinson's disease; and complications associated with chronic kidney disease and cystic fibrosis, among other health conditions. AbbVie was founded in 2012 and is based in North Chicago, Illinois.

Sell -
Mergr

Product

Company

Legal